Nucleic acid therapeutics is a growing field aiming to treat human conditions that has gained special attention due to the successful development of mRNA vaccines against SARS-CoV-2. Another type of nucleic acid therapeutics is antisense oligonucleotides, versatile tools that can be used in multiple ways to target pre-mRNA and mRNA. While some years ago these molecules were just considered a useful research tool and a curiosity in the clinical market, this has rapidly changed. These molecules are promising strategies for personalized treatments for rare genetic diseases and they are in development for very common disorders too. In this chapter, we provide a brief description of the different mechanisms of action of these RNA therapeutic mol...
The increasing number of approved nucleic acid therapeutics demonstrates the potential to treat dise...
RNA-based therapies are a new, rapidly growing class of drugs that until a few years ago were being ...
Since the identification of the DNA double-stranded helix, the gene as a target of therapy and, more...
Nucleic acids are the backbone of antisense therapy. Antisense oligonucleotide-based therapeutics in...
RNA-based therapeutics are emerging as a powerful platform for the treatment of multiple diseases. C...
RNA therapeutics involve the use of coding RNA such as mRNA as well as non-coding RNAs such as small...
Background: Antisense and other RNA-targeting strategies have the potential to impact a broad array ...
Nucleic acid-based drugs are a promising class of therapeutic agents that have important clinical ap...
Here, we discuss three RNA-based therapeutic technologies exploiting various oligonucleotides that b...
Nucleic acid therapy comprises several approaches based on nucleic acid as the active therapeutic co...
Abstract Ribonucleic acid (RNA) therapeutics are being actively researched as a therapeutic modality...
The specific targeting and inactivation of gene expression represents nowadays the goal of the mains...
Although the study of ribonucleic acid (RNA) therapeutics started decades ago, for many years, this ...
Several nucleic acid-based technologies such as short interfering RNAs (siRNA), antisense oligonucle...
Conceptual simplicity, the possibility of rational design, rel-atively inexpensive cost, and develop...
The increasing number of approved nucleic acid therapeutics demonstrates the potential to treat dise...
RNA-based therapies are a new, rapidly growing class of drugs that until a few years ago were being ...
Since the identification of the DNA double-stranded helix, the gene as a target of therapy and, more...
Nucleic acids are the backbone of antisense therapy. Antisense oligonucleotide-based therapeutics in...
RNA-based therapeutics are emerging as a powerful platform for the treatment of multiple diseases. C...
RNA therapeutics involve the use of coding RNA such as mRNA as well as non-coding RNAs such as small...
Background: Antisense and other RNA-targeting strategies have the potential to impact a broad array ...
Nucleic acid-based drugs are a promising class of therapeutic agents that have important clinical ap...
Here, we discuss three RNA-based therapeutic technologies exploiting various oligonucleotides that b...
Nucleic acid therapy comprises several approaches based on nucleic acid as the active therapeutic co...
Abstract Ribonucleic acid (RNA) therapeutics are being actively researched as a therapeutic modality...
The specific targeting and inactivation of gene expression represents nowadays the goal of the mains...
Although the study of ribonucleic acid (RNA) therapeutics started decades ago, for many years, this ...
Several nucleic acid-based technologies such as short interfering RNAs (siRNA), antisense oligonucle...
Conceptual simplicity, the possibility of rational design, rel-atively inexpensive cost, and develop...
The increasing number of approved nucleic acid therapeutics demonstrates the potential to treat dise...
RNA-based therapies are a new, rapidly growing class of drugs that until a few years ago were being ...
Since the identification of the DNA double-stranded helix, the gene as a target of therapy and, more...